Failure of BRCA1 dysfunction to alter ovarian cancer survival.

Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations

1994 • 2,460 citations

Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.

1975 • 773 citations

Tables of the number of patients required in clinical trials using the logrank test

1982 • 694 citations

Clinicopathologic Features of <EMPH TYPE="ITAL">BRCA</EMPH>-Linked and Sporadic Ovarian Cancer

2000 • 537 citations

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1996 • 427 citations

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

2000 • 322 citations

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.

1998 • 259 citations

Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience

2010 • 201 citations

Prognostic factors in ovarian cancer.

1991 • 192 citations

TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains

1995 • 179 citations

Epithelial Ovarian Carcinoma: Principles of Primary Surgery

1994 • 165 citations

p53 Mutations and Expression in Ovarian Cancers

1999 • 144 citations

Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.

1999 • 141 citations

Frequency of BRCA1 Dysfunction in Ovarian Cancer

2002 • 137 citations

BRCA1, BRCA2, and DNA Damage Response: Collision or Collusion?

1998 • 137 citations

Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse

1993 • 130 citations

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

2000 • 126 citations

Prognostic Value of p53 Genetic Changes in Colorectal Cancer

1999 • 116 citations

An abundance of p53 null mutations in ovarian carcinoma.

1996 • 102 citations

Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.

1995 • 98 citations

Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.

1998 • 97 citations

Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: New aspects and multivariate analysis

1993 • 96 citations

p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients.

2000 • 88 citations

Familial Ovarian Cancer

1993 • 83 citations

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients

2000 • 77 citations

Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma.

1996 • 43 citations

The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.

2001 • 31 citations

Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP)

2001 • 28 citations

p53 mutations and microsatellite instability in ovarian cancer: Yin and Yang

2001 • 21 citations

BRCA1 Mutations in Familial Ovarian Cancer

1999 • 20 citations